Edwards Lifesciences Unveils Structural Heart Care Innovations and Presents at Citi MedTech Day
EWEW•
Edwards Lifesciences highlighted its latest structural heart care innovations aimed at enhancing transcatheter valve therapies and improving patient outcomes. The company also presented its strategic roadmap and clinical data at Citi’s 2026 Unplugged MedTech and Life Sciences Access Day.
1. Innovation in Structural Heart Care
Edwards Lifesciences detailed advancements in transcatheter valve technologies, focusing on improved durability and delivery systems designed to enhance procedural outcomes and expand patient eligibility.
2. Presentation at Citi’s Unplugged MedTech and Life Sciences Day
The company outlined its strategic objectives and shared preliminary clinical results for its latest structural heart devices, highlighting commercial rollout timelines and upcoming trial milestones.
Related News
NVDA
Nvidia Q1 Net Income Surges 211% to $58.3B, Data Center Revenue Up 92%
NVDA•
DAO
Youdao Q1 Revenue Rises 3.8% to RMB1.3B, Marketing Jumps 20.9%
DAO•
FDS
Nvidia Q1 Revenue Soars 85% to $81.6B as Buyback Approved
FDS•
GROW
US Global Investors Sees 15% AUM Gain, 31% Revenue Growth and $2.6M Profit
GROW•
TSLA
SpaceX Files $75B IPO at $1.75T Valuation, Merger with Tesla Eyed
TSLA•
Sources
BS